Showcases Stock ranks

ASLAN Pharmaceuticals Limited (ASLN)
2.63 -0.17 (-6.07%) 01-17 16:00
Open: 2.8 Pre. Close: 2.8
High: 2.85 Low: 2.6
Volume: 425,944 Market Cap: 49M
ASLAN Pharmaceuticals Limited operates as a clinical-stage oncology and inflammatory disease focused biopharmaceutical company in the United States. It targets diseases that are prevalent in Asia, and orphan indications in the United States and Europe. The company's lead program, varlitinib, is a reversible small molecule pan-human epidermal growth factor receptor (HER), inhibitor that targets the human epidermal growth factor receptors HER1, HER2, and HER4, as well as gastric cancer. Its Varlitinib is currently being studied in a pivotal clinical trial for biliary tract cancer. In addition, the company is developing ASLAN003, an orally active potent inhibitor of human dihydroorotate dehydrogenase that is in Phase II clinical trials to treat acute myeloid leukemia; and ASLAN004, an interleukin 4/interleukin 13 receptor antibody for the treatment of severe atopic dermatitis and asthma. Further, it develops ASLAN005, an antibody that is in preclinical development targeting rece
Share on Facebook   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 2.854 - 2.867 2.867 - 2.881
Low: 2.562 - 2.578 2.578 - 2.594
Close: 2.6 - 2.626 2.626 - 2.651
Stock Technical Analysis
Target: Six months: 3.35
One year: 3.92
Support: Support1: 2.28
Support2: 1.92
Resistance: Resistance1: 2.87
Resistance2: 3.35
Pivot: 2.27
Moving Averages: MA(5): 2.58
MA(20): 2.28
MA(100): 1.85
MA(250): 2.85
MACD: MACD(12,26): 0.13
Signal(12,26,9): 0.09
%K %D: %K(14,3): 75.79
%D(3): 69.87
RSI: RSI(14): 57.87
52-Week: High: 8.18
Low: 0.35
Change(%): -16.8
Average Vol(K): 3-Month: 165909
10-Days: 69135
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.

ASLN has closed below upper band by 13.4%. Bollinger Bands are 36.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NasdaqGM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 37.99
Shares Float (M) 30.42
% Held by Insiders
% Held by Institutions 7.12
Shares Short (K) 13
Shares Short Prior Month (K)
Stock Financials
EPS -0.855
Book Value (p.s.) 0.410
PEG Ratio
Profit Margin
Operating Margin -879.37
Return on Assets (ttm) -36.2
Return on Equity (ttm) -99.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.689
Qtrly Earnings Growth
Operating Cash Flow (M) -29.20
Levered Free Cash Flow (M) -19.22
Stock Valuation
P/E -3.08
P/E Growth Ratio -0.06
P/BV 6.41
P/S 29.22
P/CF -3.42
Dividend Yield
Dividends & Splits
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator